Woods, Beth S ;
Sideris, Eleftherios ;
Sydes, Matthew R...
Woods , B S , Sideris , E , Sydes , M R , Gannon , M R , Parmar , M K B , Alzouebi , M , Attard , G , Birtle , A J , Brock , S , Cathomas , R , Chakraborti , P R , Cook , A , Cross , W R , Dearnaley , D P , Gale , J , Gibbs , S , Graham , J D , Hughes , R , Jones , R J , Laing , R , Mason , M D , Matheson , D , McLaren , D B , Millman , R , O'Sullivan , J M , Parikh , O , Parker , C C , Peedell , C , Protheroe , A , Ritchie , A W S , Robinson , A , Russell , J M , Simms , M S , Srihari , N N , Srinivasan , R , Staffurth , J N , Sundar , S , Thalmann , G N , Tolan , S , Tran , A T H , Tsang , D , Wagstaff , J , James , N D & Sculpher , M J 2018 , ' Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness ' , European urology oncology , vol. 1 , no. 6 , pp. 449-458 . https://doi.org/10.1016/j.euo.2018.06.004.
,
2018
